Safety and Body Processing Study of AD-230 in Healthy Adults
This early-stage trial tests how a new drug called AD-230 moves through the body and whether it's safe in healthy volunteers. Researchers will measure drug levels in your blood and watch for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 64 years old
- Your BMI (a measure of weight relative to height) is between 18.5 and 29.9—roughly a healthy weight range
- You have not taken an experimental drug in another trial within the last 6 months
- You are generally healthy with no major medical conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called AD-230 to understand how your body absorbs and processes it, and whether food affects this process. You'll be a healthy volunteer helping researchers gather safety information.
This early-stage study tests a new investigational drug called AD-231 to see how safe it is and how your body processes it. Researchers will compare it to a combination of three related drugs to understand which approach works best.
This study tests how two experimental drugs, called AD-236A and AD-236B, interact in the body and checks if they are safe. Healthy volunteers are needed to see how the drugs affect each other.
This trial tests three similar drugs to see how they are processed by the body and how safe they are. It is for healthy volunteers to help find the best dose and form of these medications.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This trial studies how two experimental drugs (AD-2321 and AD-2322) interact in the body and if they are safe for healthy volunteers. It is a Phase 1 study open to healthy adults.
Hear when a new Chronic Liver Disease (CLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.